Pars Planitis

Pars planitis is a type of eye inflammation (uveitis) that affects the pars plana, a part of the eye. It's a common type of uveitis, meaning inflammation inside the eye. It causes swelling and new blood vessel growth in this specific area.

Condition

What people with Pars Planitis report

Every report comes from a Lived member, sent anonymously.

Have you tried Kenalog (Triamcinolone Acetonide) for Pars Planitis?

NameHow it went

About Pars Planitis

What It Is

Pars planitis is a long-lasting inflammation inside the eye that mainly affects children, teenagers and young adults. It is a form of intermediate uveitis, meaning the inflammation is centered in the middle of the eye: the clear gel that fills the eyeball (the vitreous) and the pars plana, a narrow band of tissue near the front edge of the retina. The name is used when no underlying infection or body-wide disease can be found to explain it. The usual symptoms are floaters (drifting spots or threads in vision) and blurred vision. Unlike some other types of uveitis, the eye is often not red or painful, and mild cases are sometimes found on a routine eye exam. Both eyes are usually involved, though one is often worse than the other. Pars planitis is uncommon, and many people keep good vision, but it matters because the inflammation can lead to complications that threaten sight if it is not monitored and controlled.

Causes & Risk Factors

The cause of pars planitis is unknown. Researchers believe the immune system mistakenly targets tissue inside the eye, and certain inherited immune-system gene types appear more often in people who have it, suggesting a genetic tendency rather than a single cause. It is not contagious, and nothing a person or parent did is known to bring it on. Some of the same immune gene types are also linked to multiple sclerosis (MS), and people with pars planitis have a higher chance of developing MS later. Most people with pars planitis do not, but this link affects both the initial workup and some treatment choices.

How It's Diagnosed

An eye doctor, usually an ophthalmologist with uveitis or retina experience, makes the diagnosis by examining the eye after dilating the pupils with drops. The characteristic findings are clumps of inflammatory cells floating in the vitreous, called snowballs, and white deposits along the pars plana, called snowbanks. Seeing either one in a person with inflammation centered in the vitreous fits pars planitis. Because infections and other diseases can produce the same picture, the diagnosis is only made after they have been ruled out. Depending on age and history, testing may include blood tests for syphilis and Lyme disease, a test for tuberculosis, a chest X-ray or scan to look for sarcoidosis, and sometimes magnetic resonance imaging (MRI) of the brain to look for signs of MS. In older adults, doctors also consider a rare eye lymphoma that can imitate uveitis. Finding the cause matters because infections need different treatment, and the steroids and immune-suppressing medicines used for pars planitis could make an untreated infection worse. Imaging helps judge how active the disease is. Optical coherence tomography (OCT), a quick, painless scan of the retina, shows whether the macula, the central part of the retina used for reading and recognizing faces, is swollen. A fluorescein angiogram, in which dye injected into an arm vein is photographed as it passes through the retina's blood vessels, shows leaking vessels and active inflammation.

Treatment Options

Not everyone needs treatment. Some people, including some children, have mild inflammation with good vision and no swelling of the macula, and can be watched closely with regular exams. Treatment is started when vision drops, floaters become heavy enough to interfere with sight, the macula swells (macular edema) or other complications appear. Once treatment begins, the goal is to quiet the inflammation completely, not just partly. Care usually follows a stepwise approach. Corticosteroids (steroids) are the first step and can be given as eye drops, as an injection beside or into the eye, as a slow-release implant placed in the eye, or as pills when both eyes are badly affected. The dexamethasone implant Ozurdex, a tiny rod injected into the eye that releases steroid slowly, is approved for this kind of uveitis. Steroids work well but, especially with repeated or long-term use, raise the chance of cataract and of high eye pressure that can lead to glaucoma, so eye pressure is checked at follow-up visits. Steroid pills also carry body-wide side effects, which is one reason they are kept short. When inflammation keeps coming back or can only be controlled with ongoing steroids, doctors add a steroid-sparing medicine that calms the immune system more broadly. Methotrexate, an immune-modulating drug also used for arthritis, is a common first choice, especially in children; others include mycophenolate, a daily immune-suppressing pill also used after organ transplants. Methotrexate and mycophenolate can harm a developing baby, so anyone who could become pregnant needs reliable contraception and should talk about pregnancy plans before starting. Adalimumab (Humira, also available as several biosimilars) is an injected biologic approved for non-infectious intermediate uveitis in adults and children 2 and older. These medicines lower resistance to infection and need regular blood tests. Biologics that block tumor necrosis factor (TNF), such as adalimumab, are used with extra care in pars planitis because they can bring on or worsen nerve-insulation diseases such as MS. Surgery and laser have a role in selected cases. Vitrectomy, an operation that removes the inflamed vitreous gel, can clear dense floaters or blood, relieve pulling on the retina and sometimes reduce inflammation that has not responded to medicine. Laser treatment to the peripheral retina may be used alongside other therapy. Cataracts caused by the disease or by steroids can be removed, ideally after the eye has been free of inflammation for about three months.

What to Expect

Pars planitis is usually a long-term condition that flares and settles over years rather than a single episode, and only a minority of people have a short, self-limited course. Many people keep useful, often good, vision, particularly when inflammation is controlled and complications are caught early. In one long-term study, three quarters of eyes still saw 20/40 or better after 10 years. (On an eye chart, 20/40 means seeing at 20 feet what typical vision sees at 40 feet.) The main threat to vision is macular edema, swelling of the central retina that blurs detail. Other complications that can develop over time include cataract, a buildup of scar tissue on the retina's surface, bleeding into the vitreous, glaucoma and, less often, retinal detachment. Children face an extra risk: if one eye sees poorly for a long time during childhood, the brain can stop fully using it (amblyopia, or lazy eye), so vision in young children needs particular attention. Day to day, most people live normally, but the condition calls for regular eye visits, more often while inflammation is active and less often once it is quiet. People taking immune-suppressing medicines also need blood monitoring.

When to Seek Help

See an eye doctor soon for a dilated eye exam if you or your child notice new floaters or blurred vision that does not clear, even without pain or redness. If you already have pars planitis, contact your eye doctor promptly if your vision becomes more blurred or floaters increase gradually, the eye becomes painful or red, or a medicine causes troubling side effects. Also mention any new neurological symptoms, such as numbness, weakness or balance problems, since pars planitis is linked to MS. A sudden burst of many new floaters, flashes of light, or a dark shadow or curtain spreading across part of your vision can mean the retina is detaching. Go to an eye doctor or an emergency room right away. A sudden loss of vision, even without these signs, also needs same-day contact with your eye doctor.

Questions to Ask Your Doctor

  1. 1.What tests do we need to rule out infections, sarcoidosis or multiple sclerosis as the cause?
  2. 2.Is the inflammation active enough to need treatment now, or is it safe to watch it with regular exams?
  3. 3.If steroids are needed, how will we watch for cataract and raised eye pressure, and when would we move to a steroid-sparing medicine?
  4. 4.How often should I (or my child) be examined, and what changes in vision should prompt an earlier visit?
  5. 5.For a child, how will we check for and prevent lazy eye?

Last reviewed • Oct 2026

Educational content, not medical advice.